Cell Physiological Phenomena

12 trials 5 recruiting

Filter these 12 trials by phase, country and sponsor.

Open in Search →

Exploratory study on Azithromycin on senescence in healthy volunteers Not authorised

2025-522379-26-00 Cellular senescence and associated inflammatory status 4
Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease Pending

2024-518640-20-00 Chronic ischemic heart disease 4
A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Pati… Recruiting

2022-502959-54-00 Locally Advanced or Metastatic Non-Small Cell Lung Canc 5 2023-09-26
Pharmacokinetics, safety, and efficacy of fisetin - A phase I and pilot phase IIa study Recruiting

2023-506284-34-00 Healthy 9 2026-03-24
Changes in the wound microbiome and their impact on chronic wound healing under hyperbaric conditions Recruiting

2025-523863-39-00 chronic wounds 6 2026-03-05
Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector C… Recruiting

2024-515328-35-00 hematology 6 2025-07-02
MAGE-C2 TCR T cell therapy Recruiting

2024-516922-70-00 advanced melanoma or HNSCC 9 2024-11-29
Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency (CAP… Ended

2023-504998-20-00 Metastatic Hormone-sensitive Prostate Cancer Characteri 5 2020-09-18
Does human skeletal muscle possess an epigenetic memory of testosterone Ended

2023-507815-37-00 Healthy aging 4 2024-08-01
Evaluation of irritation potential of topical formulations on intact skin Ended

2024-511826-29-00 Dermal tolerability test: Testing for non-specific, loc 3 2024-06-20
Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients Ended

2023-504519-34-01 Chronic obstructive pulmonary disease 4 2024-02-22
A Study of EOS006215 in Adult Participants with Advanced Solid Tumors Ended

2024-520369-30-00 Solid Tumors 1